Pathway to Prevention

Pathway to Prevention screening is the first step for all TrialNet prevention studies. Screening is offered at no cost to eligible individuals to evaluate their personal risk of developing the disease. This unique screening can identify the early stages of type 1 diabetes (T1D) years before any symptoms appear. It also helps researchers learn more about how T1D develops and plan new studies exploring ways to prevent it

Sponsor

TrialNet/NIDDK(National Institute of Diabetes and Digestive and Kidney Diseases)

Principle Investigator

Diane Wherrett

Researchers

Oluwatosin Akinsiku

Recruiting time left

Days

Hours

Minutes

Seconds

Contribute

Participating in research not only gives you access to innovative treatments, but also allows you to contribute to the discovery of new therapies.

Commitment

1

Visits

15-30 mins

Duration

flex

Frequency

Locations

Online

No travel required! Online studies are usually questionnaires, surveys, audio/video meetings, or web-based experiments.

Home Visit

Home visits bring the study straight to the participant’s home for their convenience.

In-Clinic

This indicates a physical location that participants would be required to travel to for the study activities.

Clinics

< View All Studies